COMPARISON OF THE EFFECT OF SILDENAFIL AND TADALAFIL ON PULMONARY HYPERTENSION ASSOCIATED WITH HEMODYNAMICALLY SIGNIFICANT PDAS TREATMENT OF PULMONARY HYPERTENSION IN HS-PDA PATIENTS. Journal of Pharmaceutical Negative Results, [S. l.], p. 3266–3274, 2022. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/4563.. Acesso em: 21 jun. 2026.